This week one of the most anticipated court cases of the year has finally kicked off. Perhaps not “anticipated” in the sense that the OJ Simpson case was, and it probably won’t have the same global public interest the trial of Jeffrey Epstein co-conspirator Ghislaine Maxwell is expected to stoke. But jury selection for US versus Elizabeth Holmes et al started yesterday, and with it a kind of reckoning for tech hype.

Holmes was once, briefly, the darling of the start-up universe. Her medtech company Theranos was slated to “revolutionise” private health care and disrupt medical laboratory testing. She founded the company at just 19 years old, and cultivated an air of “maverick genius” about herself, trading on being a Stanford University dropout like Google founders Larry Page and Sergey Brin and Microsoft elite Steve Ballmer. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now